Alliance Pharma Dividends - APH

[ADVERT]

Best deals to access real time data!
Silver Monthly Subscription for only ~~£17.37~~
Level 2 Basic Monthly Subscription for only ~~£62.08~~
UK/US Silver Monthly Subscription for only £30.59
VAT not included

Stock Name	Stock Symbol	Market	Stock Type
Alliance Pharma Plc	APH	London	Ordinary Share

	Price Change	Price Change %	Stock Price	Last Trade
	0.00	0.0%	102.00	00:00:00

Open Price	Low Price	High Price	Close Price	Previous Close
				102.00

more quote information »

Industry Sector
PHARMACEUTICALS & BIOTECHNOLOGY

Alliance Pharma APH Dividends History

Announcement Date	Type	Currency	Dividend Amount	Period Start	Period End	Ex Date	Record Date	Payment Date	Total Dividend Amount
21/09/2021	Interim	GBX	0.56	31/12/2020	31/12/2021	23/12/2021	24/12/2021	07/01/2022	0
23/03/2021	Final	GBX	1.08	31/12/2019	31/12/2020	10/06/2021	11/06/2021	08/07/2021	1.61
22/09/2020	Interim	GBX	0.53	31/12/2019	31/12/2020	17/12/2020	18/12/2020	07/01/2021	0
24/09/2019	Interim	GBX	0.54	31/12/2018	31/12/2019	19/12/2019	20/12/2019	10/01/2020	0.54
26/03/2019	Final	GBX	0.98	31/12/2017	31/12/2018	13/06/2019	14/06/2019	11/07/2019	1.47
19/09/2018	Interim	GBX	0.487	31/12/2017	31/12/2018	20/12/2018	21/12/2018	10/01/2019	0
27/03/2018	Final	GBX	0.89	31/12/2016	31/12/2017	14/06/2018	15/06/2018	11/07/2018	1.33
13/09/2017	Interim	GBX	0.44	31/12/2016	31/12/2017	21/12/2017	22/12/2017	11/01/2018	0
29/03/2017	Final	GBX	0.807	31/12/2015	31/12/2016	15/06/2017	16/06/2017	12/07/2017	1.21
14/09/2016	Interim	GBX	0.403	31/12/2015	31/12/2016	22/12/2016	23/12/2016	12/01/2017	0
07/04/2016	Final	GBX	0.74	31/12/2014	31/12/2015	16/06/2016	17/06/2016	13/07/2016	1.1
09/09/2015	Interim	GBX	0.36	31/12/2014	31/12/2015	24/12/2015	29/12/2015	14/01/2016	0
25/03/2015	Final	GBX	0.67	31/12/2013	31/12/2014	18/06/2015	19/06/2015	15/07/2015	1
10/09/2014	Interim	GBX	0.333	31/12/2013	31/12/2014	03/12/2014	05/12/2014	15/01/2015	0
26/03/2014	Final	GBX	0.61	31/12/2012	31/12/2013	11/06/2014	13/06/2014	10/07/2014	0.91
11/09/2013	Interim	GBX	0.303	31/12/2012	31/12/2013	04/12/2013	06/12/2013	15/01/2014	0
21/03/2013	Final	GBX	0.55	31/12/2011	31/12/2012	12/06/2013	14/06/2013	11/07/2013	0.83
12/09/2012	Interim	GBX	0.275	31/12/2011	31/12/2012	05/12/2012	07/12/2012	15/01/2013	0
22/03/2012	Final	GBX	0.5	31/12/2010	31/12/2011	13/06/2012	15/06/2012	12/07/2012	0.75
07/09/2011	Interim	GBX	0.25	31/12/2010	31/12/2011	30/11/2011	02/12/2011	13/01/2012	0
23/03/2011	Final	GBX	0.4	31/12/2009	31/12/2010	15/06/2011	17/06/2011	14/07/2011	0.57
08/09/2010	Interim	GBX	0.17	31/12/2009	31/12/2010	01/12/2010	03/12/2010	14/01/2011	0
24/03/2010	Final	GBX	0.23	31/12/2008	31/12/2009	16/06/2010	18/06/2010	15/07/2010	0.3
09/09/2009	Interim	GBX	0.07	30/12/2008	30/06/2009	02/12/2009	04/12/2009	15/01/2010	0

Top Dividend Posts

Date	Subject
26/11/2021 13:16	km18: From WealthOracleAM... The company we cover today is a very particular business, as it brings expertise to the marketing and regulatory management of products, ensuring it reaches a wide range of people. Alliance is a UK-based specialty pharmaceutical company. They are neither a manufacturer, nor a proper pharmaceuticals developer. This allows them to run an asset-light business (without all of the warehousing and logistics) and keep their focus on the areas of the business where they are experts. A simpler way to describe them would be a retailer for healthcare products. Acquisitions are a rare sight, with one done last year (Biogix) and the previous in 2012, resulting in a low goodwill figure. Fundamentals look healthy. Revenue CAGR is currently at 21.8%. The one-off drop in EPS from last year is mainly due to non-cash impairment and amortisation charges and the acquisition costs relating to Biogix transaction. This also pushed the ROCE down to 3.41%, but the ratio is rising by a CAGR of 7.99%. Free cash flow was strong supported by favourable movements in working capital and the total dividend was significantly ahead of 2019. https://wealthoracle.co.uk/detailed-result-full/APH/153 Read Full Thread Follow Reply
21/9/2021 15:16	wad collector: This BB is humming with excitement ever since I acquired some in March. Usually shares drop when I buy them and the BB gets busy. I like this. Though won't buy much with the dividend. Interim results for the six months ended 30 June 2021 Strong growth from Consumer Healthcare brands and integration of Amberen complete Full year outlook in line with market expectations Alliance Pharma plc (AIM: APH), the international healthcare group, announces its interim results for the six months ended 30 June 2021 (the "Period"). HIGHLIGHTS -- The Group traded strongly in the Period with an excellent performance from Kelo-cote(TM), an uplift in revenue from Prescription Medicines and a significant contribution from recently acquired Amberen(TM) -- See-through revenue in total up 24% (+28% on a constant currency basis ("CCY")) to GBP80.9m; like-for-like ("LFL") see-through revenue, which excludes Amberen, up 9% (+12% CCY); statutory revenue up 27% to GBP78.6m (H1 2020 GBP61.7m) o Strong performance from Consumer Healthcare brands, with see-through revenue up 30% overall (+35% CCY) -- Kelo-cote revenue up 54% (+62% CCY) -- LFL Consumer Healthcare revenue up 8% (+12% CCY) o Prescription Medicines revenue up 12% (+12% CCY) -- Underlying gross margin up 4.7 % to 63.8% of see-through revenue (H1 2020: 59.1%), reflecting favourable changes in product mix; statutory gross margin up 3.1% to 65.6% (H1 2020: 62.5%) -- Underlying profit before tax up 24% to GBP20.1m (H1 2020: GBP16.3m); reported profit before tax GBP16.5m (H1 2020: GBP0.6m) -- Free cash flow GBP6.5m (H1 2020: GBP10.5m), reflecting the expected reversal of favourable working capital movements in Q4 2020 and the timing of sales within the Period -- Leverage reduced to 2.21 times from 2.43 times at December 2020 and expected to fall below 2.0 times by the end of the year -- Amberen integration complete and trading in line with management expectations -- Interim dividend payment of 0.563p, up 5% (interim dividend 2020: 0.536p) Read Full Thread Follow Reply
23/3/2021 08:39	2vdm: The recorded webcast will also be made available at the investor section of Alliance's website, hxxps://www.alliancepharmaceuticals.com/investors/ Read Full Thread Follow Reply
18/2/2021 09:52	2vdm: RNSthis a.m.: Alliance Pharma plc (AIM: APH), the international healthcare group, will announce its results for the 12 months ended 31 December 2020 on Tuesday 23 March 2021. A conference call for analysts will be held at 10.30am on 23 March 2021; analysts who require dial-in details, please contact Buchanan at alliancepharma@buchanan.uk.com. A recorded webcast of the analyst conference call, including investor presentation slides, will be made available during the afternoon of 23 March 2021 at this link: hxxps://webcasting.buchanan.uk.com/broadcast/60180f8da6bfbf43d06ac2ea The recorded webcast will also be made available at the investor section of Alliance's website, hxxps://www.alliancepharmaceuticals.com/investors/. For more information, please contact Buchanan on 020 7466 5000 or email alliancepharma@buchanan.uk.com. Read Full Thread Follow Reply
04/1/2021 23:27	thewheeliedealer: Hi all, My mate Peter @Conkers3 and myself did a ‘Twin Petes Investing’ Podcast a few days ago and part of our discussion includes APH and some others with a similar business model. We also chatted about loads of other Stocks and Ideas for research and a fair bit of educational stuff with regards to Investing and Portfolio Management. Anyway, if you use Youtube, Apple, Audioboom, Overcast or Spotify you can find it under the 'Conkers Corner' Channel (you want Podcast TPI 39) and you can find it on Soundcloud at the link below. I hope you enjoy it and find it useful, we try to keep them light and they are totally unscripted, not like all the stuffy financial fodder you are probably more used to !! Happy New Lockdown !! WD @wheeliedealer hTTps://soundcloud.com/user-479955511/conkers3-wheeliedealer-39-2064-profit-aph-clin-merc-pdd-axs-som-itm-adm-swg-vle-ai Read Full Thread Follow Reply
29/12/2020 22:40	wba1: Interesting acquisition. I have held this share for a few years, having bought in the low 40s. I originally bought as the business model bears some resemblance (although more OTC focused) to Galen, a company which made me very good profits in the early 2000s. And the more I see of APH the more it behaves like Galen - low risk, throws off free cash flow reliably and makes few mistakes in its dealings. I suspect this deal will be the last until 2022 and I may look to slice some profit if it tops 100p. Read Full Thread Follow Reply
25/9/2020 06:50	2vdm: Also reduced my holdings substantially. I've done very well out of APH and still hold, but I can't see it going anywhere at the moment, although I may re-visit when we have more news Read Full Thread Follow Reply
22/9/2020 16:44	winnings1: AMUNRO- What stock did you buy to replace APH, did it work out o.k. for you? Read Full Thread Follow Reply
22/9/2020 08:54	amunro: Tesla is an interesting one. Are they are a car maker or innovator of next gen technology like self driving cars and batteries? As an investor sometimes you just need to follow the market, make money, with the view to getting out when things dive. Its all about managing risk. I got out of APH as I want the money to grow faster than APH offers. Read Full Thread Follow Reply
09/4/2020 10:05	scillyfool: 2vdm, I'm sure APH have their eyes on prospective struggling competitors, but as the integration of Nizoral won't be completed uhtil June I just thought that they should concentrate on getting that integrated before taking on further acquisitions. My own thoughts are that in future many previous company development strategies may need to be rethought. First priority - survival. A company with no debt and a cash pile can better survive any market shocks and not only keep investors happy by continuing to pay dividends, but perhaps be even better placed to buy struggling competitors. Let's hope that after all this Covid-19 is over APH pay a special dividend to their loyal shareholders equal to the pulled final dividend to reassure us. Read Full Thread Follow Reply

Advertise Here

Your Recent History

LSE

APH

Alliance P..

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US

P: V: D:20211207 07:17:40